Industry Briefs: July 30, 2012 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Industry Briefs: July 30, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.


Company News

Coldstream Laboratories is expanding its Louisville, Kentucky, sterile-manufacturing facility. Read More

Dendreon has announced a restructuring plan to reduce costs by approximately $150 million annually. The plan includes the closure of its Morris Plains, New Jersey, manufacturing facility. Read More

GlaxoSmithKline has announced the acquisition of 79% of Human Genome Sciences’s shares, and is beginning a subsequent offering period to acquire the remaining shares. Read More

NSF International has acquired Becker & Associates Consulting, a clinical, regulatory, and scientific-consulting firm. Read More

People Notes

Array BioPharma has named Andrew Robbins as senior vice-president of commercial operations. Read More

Daicel has appointed Dieter Heckmann as executive officer. He will assume responsibility for global operations of the Chiral Pharmaceutical Ingredients company, reporting to Misao Fudaba, president and CEO of Daicel.

Quanticate has appointed Sally Du Toit as vice-president of pharmacovigilance and Chris Cramer as vice-president of clinical data management. Read More

Takeda Pharmaceutical has appointed Christopher Hohman as vice-president of its corporate communications department. Read More

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here